Russia’s participation in the largest international register CLARIFY, monitoring coronary heart disease patients

1. Borer JS, Fox K, Jaillon P, et al. Anti-anginal and anti-ischemic effects of ivabradine, an If inhibitor, in stable angina: a randomized, double-blinded, multicentered, placebo-controlled trial. Circulation 2003; 107: 817-23.

2. Tardif JC, Ford I, Tendera M, Bourassa MG. Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005; 26: 252936.

3. Ruzyllo W, Ford I, Tendera M, et al. Antianginal and anti-ischemic effects of ivabradine compared to amlodipine in patients with stable effort angina: a 3-month randomized, double-blind, multicentre, noninferiority trial. Drugs 2007; 67: 393-405.

4. Tardif JC, Ponikowski P, Kahan T. for the ASSOCIATE. Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-bloker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J 2009; 30: 540-8.

5. Fox K, Ford L, Steg PG, et al. on behalf of the BEUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet 2008; 37: 807-16.

6. Fox1 K, Ford I, Steg PG, et al. on behalf of the BEAUTIFUL investigators. Eur Heart J FAST Track doi:10.1093/eurheartj/ ehp358. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.

7. Карпов Ю.А., Деев А.Д. от имени участников программы АЛЬТЕРНАТИВА. Программа АЛЬТЕРНАТИВА – исследование антиангинальной эффективности и переносимости кораксана (ивабрадина) и оценка качества жизни пациентов со стабильной стенокардией: результаты эпидемиологического этапа. Кардиоваск тер профил 2008; 5: 30-5.

8. ВНОК. Диагностика и лечение стабильной стенокардии. Российские рекомендации (второй пересмотр). Кардиоваск тер профил 2008; приложение 4.